6 terminated. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Terminated 6 |
| Phase 2 | 1 | Terminated 1 |
Follow PTSD: new trials by email Literature Review of PTSD trials Research Report on PTSD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSD NYX-783, Placebo - PTSD | Phase 2 / Phase 3 | Terminated | Aptinyx | 121 | 2021-12-13 | 2023-04-07 |
| A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD TNX-102 SL, Placebo SL Tablets - PTSD | Phase 3 | Terminated | Tonix Pharmaceuticals, Inc. | 192 | 2019-03-07 | 2025-02-06 |
| Combined Treatment of Prolonged Exposure and Pramipexole for Posttraumatic Stress Disorder and Depression PE/Pramipexole - PTSD, MDD | Phase 3 | Terminated | Research Foundation for Mental Hygiene, Inc. | 1 | 2019-02-19 | 2019-11-26 |
| 12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients TNX-102 SL - PTSD | Phase 3 | Terminated | Tonix Pharmaceuticals, Inc. | 190 | 2017-06-20 | 2025-02-06 |
| Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD TNX-102 SL, Placebo SL Tablet - PTSD | Phase 3 | Terminated | Tonix Pharmaceuticals, Inc. | 358 | 2017-03-27 | 2024-05-22 |
| Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD) Placebo, Brexpiprazole - Post-traumatic Stress Disorder, PTSD | Phase 3 | Terminated | H. Lundbeck A/S | 417 | 2013-12-01 | 2017-03-13 |
Stress Disorders, Post-Traumatic (6)
Mental Disorders (6) · Stress Disorders, Traumatic (6) · Trauma and Stressor Related Disorders (6)
brexpiprazole (1) · cyclobenzaprine (1)
Tonix Pharmaceuticals, Inc. (3) · Aptinyx (1) · H. Lundbeck A/S (1) · Research Foundation for Mental Hygiene, Inc. (1)
United States (6) · Estonia (1) · Finland (1) · France (1) · Italy (1) · Poland (1) · Serbia (1) · South Africa (1) · Sweden (1)
Denise Bedoya (1) · Greg Sullivan, MD (1) · Gregory M Sullivan, MD (1) · Yuval Neria, PhD (1)